Zynerba Pharmaceuticals (ZYNE) announced that it has appointed Jim Fickenscher as Chief Financial Officer and VP, Corporate Development replacing Richard Baron effective September 13. Previously, he was SVP, CFO at Antares Pharma. The company has also appointed Nancy Tich, MS, Ph.D., to the newly created position of VP, Clinical. Previously, she was Senior Director, Project Management at Covance.